Form 4: USANA Chief Legal Officer Sells Shares

USANA Health Sciences Chief Legal Officer Joshua Foukas sold 3,791 shares of common stock on May 7, 2026.

Summary

• Joshua Foukas, Chief Legal Officer of USANA Health Sciences, executed a sale of 3,791 shares of common stock.
• The transaction occurred on May 7, 2026, at a price of $19.82 per share.
• Following this transaction, the reporting person holds zero shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine disclosure of an executive's personal financial transaction.

Positives

• The transaction represents a standard divestment by an executive, which is common for liquidity or personal financial planning purposes.

Negatives

• The sale of shares by a high-ranking executive can sometimes be perceived by the market as a lack of confidence in the short-term stock performance.

Risks

• Insider selling activity may influence market sentiment regarding the company's future valuation.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling is a routine occurrence in the health and wellness sector, often related to tax obligations or pre-planned diversification strategies rather than fundamental shifts in company health.

Comparison to Industry Standards

• The transaction size is relatively small compared to the total market capitalization of USANA Health Sciences.
• Executive stock sales are standard practice across the consumer goods and nutritional supplement industries.

Stakeholder Impact

• Minimal impact expected on shareholders as this is a routine insider transaction.

Key Dates

Keywords

USANA, USNA, Insider Trading, Form 4, Equity, Health Sciences